Excelvior 5 & 20 5 mg, 20 mg FC Tablet

Excelvior 5 & 20 5 mg, 20 mg FC Tablet

S4
PDF Leaflet Revision Date: 03 October 2023

API: Tadalafil | Company: Trinity Pharma

Clinical Summary

Quick overview from the medicine insert

Indication

Treatment of erectile dysfunction.

Dosage (summary)

5 mg once daily or 20 mg prior to sexual activity.

Onset of Action / Duration

Onset: 16 mins, Duration: up to 36 hours

Special Populations

  • Renal impairment
  • Hepatic impairment

Pregnancy & Breastfeeding

Not recommended during pregnancy or breastfeeding.

Key Drug Interactions

  • Nitrates
  • CYP3A4 inhibitors
  • Alpha-adrenergic blockers

Contraindications

  • Hypersensitivity to tadalafil
  • Severe hepatic insufficiency
  • Use with nitrates

Common side effects

  • Headache
  • Dizziness
  • Flushing
  • Dyspepsia

Counselling Points

  • Take as prescribed
  • Avoid nitrates
  • Report sudden vision or hearing loss

Serious warnings

  • Cardiovascular risk with sexual activity
  • Risk of priapism
  • Visual and hearing loss
Important Disclaimer

The Excelvior 5 & 20 5 mg, 20 mg FC Tablet professional information leaflet below is the property of Trinity Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

Healthcare Professionals Only

This content is for registered healthcare professionals

Sign in or create a free account to read the full package insert.

Free for HPCSA-registered professionals. Powered by Medinsert.

Successfully Stashed! 💊

This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

View My Favourites